Cargando…

Chronological analysis of the gut microbiome for efficacy of atezolizumab‐based immunotherapy in non‐small cell lung cancer: Protocol for a multicenter prospective observational study

BACKGROUND: Cancer immunotherapy with immune checkpoint inhibitors (ICIs) is an innovative treatment for non‐small cell lung cancer (NSCLC). Recently, the specific composition of the gut microbiome before initiation of cancer immunotherapy has been highlighted as a predictive biomarker in patients u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shoji, Fumihiro, Miura, Naoko, Tagawa, Tetsuzo, Tsukamoto, Shuichi, Okamoto, Tatsuro, Yamazaki, Koji, Hamatake, Motoharu, Takeo, Sadanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527175/ https://www.ncbi.nlm.nih.gov/pubmed/36063818 http://dx.doi.org/10.1111/1759-7714.14640

Ejemplares similares

Preoperative Immune-Nutritional Abnormality Predicts Poor Outcome in Elderly Non-Small-Cell Lung Cancer Patients with Comorbidities
por: Miura, Naoko, et al.
Publicado: (2020)

Does short-term cessation of smoking before lung resections reduce the risk of complications?
por: Takenaka, Tomoyoshi, et al.
Publicado: (2020)

Survival after recurrence following surgical resected non-small cell lung cancer: A multicenter, prospective cohort study
por: Takenaka, Tomoyoshi, et al.
Publicado: (2022)

The clinical impact of concomitant medication use on the outcome of postoperative recurrent non-small-cell lung cancer in patients receiving immune checkpoint inhibitors
por: Takada, Kazuki, et al.
Publicado: (2022)

Induction immunotherapy followed by surgery for hilar unicentric Castleman disease
por: Shoji, Fumihiro, et al.
Publicado: (2022)

Is radical local therapy effective in postoperative recurrent EGFR ‐mutated non‐small cell lung cancer?
por: Takenaka, Tomoyoshi, et al.
Publicado: (2023)

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study
por: Takada, Kazuki, et al.
Publicado: (2022)

Assessment of pleural air leakage using digital chest drainage system after surgical pulmonary resection: Comparison of visible alveolar air leakage with the digital value measured by a digital chest drainage system
por: Mori, Ryo, et al.
Publicado: (2017)

Gut microbiota diversity and specific composition during immunotherapy in responders with non-small cell lung cancer
por: Shoji, Fumihiro, et al.
Publicado: (2022)

Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer
por: Shoji, Fumihiro, et al.
Publicado: (2020)

Impact of Preoperative Immunonutritional Support in Patients Undergoing Elective Thoracic Surgery
por: Shoji, Fumihiro, et al.
Publicado: (2021)

Robot‐assisted thoracic surgery for intercostal cavernous hemangioma
por: Shoji, Fumihiro, et al.
Publicado: (2022)

Artificial intelligence-derived gut microbiome as a predictive biomarker for therapeutic response to immunotherapy in lung cancer: protocol for a multicentre, prospective, observational study
por: Shoji, Fumihiro, et al.
Publicado: (2022)

Cumulative experience of the anterior approach in robot-assisted thoracic surgery for lung cancer patients
por: Yamazaki, Koji, et al.
Publicado: (2021)

ALK‐positive lung cancer in a patient with recurrent brain metastases and meningeal dissemination who achieved long‐term survival of more than seven years with sequential treatment of five ALK‐inhibitors: A case report
por: Yamamoto, Keisuke, et al.
Publicado: (2021)

Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph‐node‐positive lung cancer patients
por: Katsura, Masakazu, et al.
Publicado: (2017)

Dramatic response to pembrolizumab with chemotherapy followed by salvage surgery in a lung cancer patient
por: Saito, Shunichi, et al.
Publicado: (2021)

Resection of Pulmonary Metastases 12 Years after Initial Surgery for a Benign Pheochromocytoma
por: Ueda, Michiko, et al.
Publicado: (2020)

Stage IV pleomorphic carcinoma of the lung without recurrence for 6 years: a case report
por: Miura, Naoko, et al.
Publicado: (2017)

Impact of the pretreatment prognostic nutritional index on the survival after first‐line immunotherapy in non‐small‐cell lung cancer patients
por: Oku, Yuka, et al.
Publicado: (2023)

Weakly-supervised learning for lung carcinoma classification using deep learning
por: Kanavati, Fahdi, et al.
Publicado: (2020)

Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC
por: Toyozawa, Ryo, et al.
Publicado: (2020)

The significant influence of having children on the postoperative prognosis of patients with nonsmall cell lung cancer: A propensity score‐matched analysis
por: Takamori, Shinkichi, et al.
Publicado: (2018)

Functional microbiome deficits associated with ageing: Chronological age threshold
por: Ruiz‐Ruiz, Susana, et al.
Publicado: (2019)

Human Skin, Oral, and Gut Microbiomes Predict Chronological Age
por: Huang, Shi, et al.
Publicado: (2020)

A deep learning model for the classification of indeterminate lung carcinoma in biopsy whole slide images
por: Kanavati, Fahdi, et al.
Publicado: (2021)

Mutational signatures in squamous cell carcinoma of the lung
por: Osoegawa, Atsushi, et al.
Publicado: (2021)

Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab
por: Hsu, Chiun, et al.
Publicado: (2021)

Chronological Rehabilitation Treatment Varying by Stage for Constructive Disability
por: Okamoto, Takana, et al.
Publicado: (2023)

Malignant schwannoma of the upper mediastinum originating from the vagus nerve
por: Shoji, Fumihiro, et al.
Publicado: (2005)

Clinical significance of part-solid lung cancer in the eighth edition TNM staging system
por: Okamoto, Tatsuro, et al.
Publicado: (2021)

The impact of immune-inflammation-nutritional parameters on the prognosis of non-small cell lung cancer patients treated with atezolizumab
por: Matsubara, Taichi, et al.
Publicado: (2020)

Relationship between obstructive lung disease and non-small cell lung cancer
por: Akamine, Takaki, et al.
Publicado: (2020)

Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma
por: Satake, Tomoyuki, et al.
Publicado: (2023)

Erratum to “Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab”
Publicado: (2021)

Localized malignant pleural mesothelioma mimicking an anterior mediastinal tumor
por: Hino, Takuya, et al.
Publicado: (2019)

Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab
por: Kamitani, Rei, et al.
Publicado: (2022)

Chronology of Anæsthesia
Publicado: (1868)

Prognostic value of postoperative decrease in serum albumin on surgically resected early-stage non-small cell lung carcinoma: A multicenter retrospective study
por: Kinoshita, Fumihiko, et al.
Publicado: (2021)

Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
por: Yano, Shigeki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n773tijlgnqkilkfmg601iq4e9